Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction
Authors:
- 12 July 2016
- journal article
- research article
- Published by Hindawi Limited in Andrologia
- Vol. 49 (4) , e12634
Abstract
Waist circumference is considered a useful predictor of obesity-associated cardiovascular risk, but its use as an indicator of sexual health status and quality of life (QoL) in hypogonadal men is unknown. We investigated whether three measurements of obesity, weight, body mass index and waist circumference, correlate with the International Index of Erectile Function-5 (IIEF-5), the Aging Males' Symptoms (AMS) and the International Prostate Symptom Score (IPSS) questionnaires. A total of 261 patients were enrolled in a prospective study on hypogonadism treatment with intramuscular long-acting testosterone undecanoate. Patients with total testosterone ≤3.5 ng ml-1 were enrolled, and baseline demographic data were recorded. Patient's response to IIEF, IPSS and AMS standardised questionnaires was recorded to evaluate health-related QoL. The mean length of treatment and follow-up was 4.7 years (max 6 years). ANOVA regression analysis showed that waist circumference was significantly inversely proportional to IIEF-5 and directly proportional to AMS and IPSS. Weight was inversely proportional to IIEF and directly proportional to IPSS but not associated with AMS. BMI had no proportionality to measurements of sexual function and quality of life. These results suggest that among weight, BMI and waist circumference, the latter is the best predictor of health-related QoL in men with hypogonadism.Keywords
This publication has 29 references indexed in Scilit:
- Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes‐related quality of lifeClinical Endocrinology, 2012
- Androgens and estrogens in benign prostatic hyperplasia: Past, present and futureDifferentiation, 2011
- Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct CohortsThe Journal of Clinical Endocrinology & Metabolism, 2011
- The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile DysfunctionJournal of Andrology, 2009
- Lower urinary-tract symptoms and testosterone in elderly menWorld Journal of Urology, 2008
- Central Obesity is an Independent Predictor of Erectile Dysfunction in Older MenJournal of Urology, 2006
- Testosterone Replacement Therapy for Older MenJournal of Andrology, 2006
- Testosterone and men's quality of lifeThe Aging Male, 2006
- ObesityThe Lancet, 2005
- Pathophysiology and Pathogenesis of Visceral Fat ObesityObesity Research, 1995